RG
GILD icon

Rathbones Group’s Gilead Sciences GILD Stock Holding History

Rathbones Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$395K Sell
2,835
-130
-4% -$18.2K ﹤0.01% 486
2025
Q4 		$364K Buy
2,965
+20
+0.7% +$2.43K ﹤0.01% 495
2025
Q3 		$327K Buy
2,945
+75
+3% +$8.53K ﹤0.01% 503
2025
Q2 		$318K Sell
2,870
-473
-14% -$50.3K ﹤0.01% 489
2025
Q1 		$375K Sell
3,343
-52
-2% -$5.37K ﹤0.01% 445
2024
Q4 		$314K Buy
3,395
+125
+4% +$11.3K ﹤0.01% 466
2024
Q3 		$274K Hold
3,270
– – ﹤0.01% 498
2024
Q2 		$224K Sell
3,270
-422
-11% -$28.2K ﹤0.01% 535
2024
Q1 		$270K Sell
3,692
-493
-12% -$37.9K ﹤0.01% 507
2023
Q4 		$339K Buy
4,185
+150
+4% +$11.7K ﹤0.01% 457
2023
Q3 		$302K Buy
+4,035
New +$310K ﹤0.01% 476
2022
Q3 		– Sell
-4,369
Closed -$270K – 423
2022
Q2 		$270K Sell
4,369
-1,055
-19% -$65.3K ﹤0.01% 363
2022
Q1 		$322K Hold
5,424
– – ﹤0.01% 348
2021
Q4 		$394K Sell
5,424
-847
-14% -$58.3K ﹤0.01% 331
2021
Q3 		$438K Sell
6,271
-2,626
-30% -$184K ﹤0.01% 320
2021
Q2 		$613K Buy
8,897
+129
+1% +$8.61K 0.01% 289
2021
Q1 		$567K Sell
8,768
-950
-10% -$61.3K 0.01% 283
2020
Q4 		$566K Sell
9,718
-137
-1% -$8.27K 0.01% 271
2020
Q3 		$623K Hold
9,855
– – 0.01% 244
2020
Q2 		$758K Buy
9,855
+1,004
+11% +$76.9K 0.02% 218
2020
Q1 		$662K Buy
8,851
+1,956
+28% +$135K 0.02% 197
2019
Q4 		$448K Sell
6,895
-350
-5% -$22.8K 0.01% 243
2019
Q3 		$459K Buy
7,245
+1,175
+19% +$76.8K 0.01% 241
2019
Q2 		$410K Buy
6,070
+523
+9% +$34.4K 0.01% 238
2019
Q1 		$361K Buy
5,547
+167
+3% +$11.1K 0.01% 244
2018
Q4 		$337K Sell
5,380
-8,905
-62% -$622K 0.01% 246
2018
Q3 		$1.1M Sell
14,285
-125
-0.9% -$9.44K 0.04% 168
2018
Q2 		$1.02M Buy
14,410
+62
+0.4% +$4.38K 0.04% 167
2018
Q1 		$1.08M Buy
14,348
+267
+2% +$21.2K 0.04% 163
2017
Q4 		$1.01M Sell
14,081
-140
-1% -$10.6K 0.04% 169
2017
Q3 		$1.15M Buy
14,221
+90
+0.6% +$6.88K 0.05% 158
2017
Q2 		$1M Buy
14,131
+6,677
+90% +$444K 0.04% 164
2017
Q1 		$506K Sell
7,454
-11,639
-61% -$818K 0.02% 210
2016
Q4 		$1.37M Buy
19,093
+333
+2% +$24.8K 0.07% 135
2016
Q3 		$1.48M Sell
18,760
-1,072
-5% -$87.1K 0.08% 127
2016
Q2 		$1.65M Buy
19,832
+3,531
+22% +$313K 0.09% 115
2016
Q1 		$1.5M Sell
16,301
-138,270
-89% -$12.5M 0.09% 115
2015
Q4 		$14.4M Buy
154,571
+710
+0.5% +$73.9K 0.91% 37
2015
Q3 		$15.1M Buy
153,861
+4,200
+3% +$466K 1.01% 34
2015
Q2 		$17.5M Sell
149,661
-2,050
-1% -$224K 1.14% 25
2015
Q1 		$14.9M Sell
151,711
-387
-0.3% -$39.3K 0.99% 36
2014
Q4 		$14.3M Buy
152,098
+275
+0.2% +$28.4K 0.94% 38
2014
Q3 		$16.2M Buy
151,823
+141,240
+1,335% +$13.8M 1.12% 23
2014
Q2 		$877K Buy
10,583
+640
+6% +$49.8K 0.06% 155
2014
Q1 		$705K Buy
+9,943
New +$780K 0.06% 163
2013
Q4 		– Sell
-10,350
Closed -$651K – 232
2013
Q3 		$651K Hold
10,350
– – 0.08% 150
2013
Q2 		$531K Buy
+10,350
New +$539K 0.07% 148

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Rathbones Group's GILD Position: Q1 2026 in Review

Rathbones Group reduced its Gilead Sciences (GILD) stake by 4.4% in Q1 2026, selling an estimated $18.2K and leaving 2,835 shares worth $395K. The position accounts for ﹤0.01% of the portfolio, ranked #486.

Rathbones Group first reported a position in GILD in Q2 2013 and has held it in 47 quarters since. The position peaked at $17.5M in Q2 2015. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Rathbones Group held 2,835 shares of Gilead Sciences worth $395K as of Q1 2026.
  • Rathbones Group sold 130 Gilead Sciences shares in Q1 2026, an estimated $18.2K.
  • Gilead Sciences made up ﹤0.01% of Rathbones Group's portfolio in Q1 2026, its #486 holding.
  • Rathbones Group first reported a position in Gilead Sciences in Q2 2013 and has held it in 47 quarters since.
  • Rathbones Group's Gilead Sciences position peaked at $17.5M in Q2 2015.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Rathbones Group's 13F filing for Q1 2026, filed 12 May 2026.